fbpx

OVERVIEW

The pursuit of health sector efficiency and value for money are central dimensions of health care performance in GCC countries. Pharmacoeconomics and healthcare technologies assessment (HTA), are key capabilities to support decision making and provide valuable insights to management and policy making in healthcare.
The event is a strategic meeting, gathering key stakeholders to explore key issues and latest advances in the areas of Pharmacoeconomics, value-based Healthcare and evidence-based medication, HTA and outcomes to achieve regulatory adherence, analyse costs and benefits, and improve access to lifesaving medicines and ensure affordability of essential medicines.

    Who Should Attend

  • Regulatory authorities
  • Pharmacoeconomists
  • Health Economists
  • Health Technology Assessment Specialists
  • Payers
  • Healthcare providers
  • Pharma industry
  • Pharmacists and more

KEY BENEFITS OF ATTENDING

  • Highlight future opportunities and challenges in developing the healthcare and research economy in the GCC countries
  • Discuss the novel approaches to value assessment, achieving cost effective healthcare solutions and access to innovative medicines in the GCC
  • Understanding the principles of outcome based healthcare and evidence based medication
  • Reviewing pharmacoeconomics and outcomes research strategies
  • Exploring the real world data, the burden of disease and HTA to make proper assessments and support decision making

Summit Chairman

Ahmed Al Jedai
Ahmed Al Jedai

Pharm.D., M.B.A., BCPS, FCCP, FAST, FCCP, FASHP, Founding President, Saudi Society of Clinical Pharmacy (SSCP), Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Consultant Clinical Pharmacist, Solid Organ Transplant, King Faisal Specialist Hospital & Research Centre, KSA

Scientific Committee Chair 

Hajer Al-Mudaiheem
Hajer Al-Mudaiheem

Pharm.D., MSc. Clinical pharmacy, CLSSBB Advisor, Assistant Deputy for Therapeutic Supportive Services, Director, Drug Policy and Regulation Department Ministry of Health, KSA

Summit Packages

2-Days Summit

Hospital and Community Pharmacists

Pharmaceutical Companies and Solution Providers

for Group Registration

Please contact: +971 4 361 9616

Scientific Committee Members

Ahmed Al Jedai
Ahmed Al Jedai

Pharm.D., M.B.A., BCPS, FCCP, FAST, FCCP, FASHP, Founding President, Saudi Society of Clinical Pharmacy (SSCP), Professor, Colleges of Medicine and Pharmacy, Alfaisal University, Consultant Clinical Pharmacist, Solid Organ Transplant, King Faisal Specialist Hospital & Research Centre, KSA

Amin Elshamy
Amin Elshamy

Consultant of Wellbeing and SDGs, Ministry of Health and Prevention, UAE

Anas Hamad
Anas Hamad

PhD, MSc, DMS, BPharm, RPh, Director of Pharmacy Department, National Center for Cancer Care & Research NCCCR, Qatar

Hajer Al-Mudaiheem
Hajer Al-Mudaiheem

Pharm.D., MSc. Clinical pharmacy, CLSSBB Advisor, Assistant Deputy for Therapeutic Supportive Services, Director, Drug Policy and Regulation Department Ministry of Health, KSA

Khuloud Bin Rafeea
Khuloud Bin Rafeea

Director of Drugs and Medical Products, Department of Health, Abu Dhabi, Abu Dhabi, UAE

Maryam Alowayesh
Maryam Alowayesh

PhD, MSc, Assistant Professor, School of Pharmacy, College of Pharmacy – Kuwait University, President, ISPOR Kuwait Chapter, Kuwait

Mouna Jameleddine
Mouna Jameleddine

Director, Health Technology Assessment Department, National
Authority for Assessment and Accreditation in Healthcare (INEAS), Tunisia

Sara Al Dallal
Sara Al Dallal

MBBS, MSc, President, Emirates Health
Economics Society, Emirates Medical Association; Senior Health Service Specialist, Dubai Health Authority, UAE

Platinum Sponsors

Amgen logo
Astellas logo

Gold Sponsors

astra-zeneca
astra-zeneca

Silver Sponsors

astra-zeneca
astra-zeneca
astra-zeneca
astra-zeneca
astra-zeneca
astra-zeneca
astra-zeneca
astra-zeneca
astra-zeneca

Media Partners

astra-zeneca
astra-zeneca
astra-zeneca
astra-zeneca
astra-zeneca